ETRAVIRINE

SynDRA canonical compound SYN0003110 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYP3A4
Mechanism of action	Non-nucleoside reverse transcriptase inhibitor
Indication	human immunodeficiency virus (HIV-1)
Disease area	infectious disease

All known targets

Non-Nucleoside Reverse Transcriptase Inhibitors
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Anti-Infective Agents
Antiviral Agents
Enzyme Inhibitors
Nucleic Acid Synthesis Inhibitors
Reverse Transcriptase Inhibitors
Cytochrome P450 2C19 Inhibitors
P-Glycoprotein Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers

intelence
etravirin
R-165335
TMC-125
Etravirina
R165335
TMC125
Intelence
DAPY deriv
Diaminopyrimidine deriv
Intelence (TN)
Intelence(TM)
R165335-TMC125
Etravirine (JAN/USAN/INN)
TMC-125/R-165335
4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile
4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE
4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
65B
ETR
R 165335
TMC 125
0C50HW4FO1
TMC125 cpd
CHEBI:63589
etravirinum
RefChem:57536
DTXCID40103903
J05AG04
Etravirine (TMC125)
MFCD09837879
Etravirine-d8
C20H15BrN6O
UNII-0C50HW4FO1
Etravirine CRS
Etravirine [USAN:INN:BAN:JAN]
Etravirine [INN]
Etravine; Etravirine